JP2019527228A5 - - Google Patents

Download PDF

Info

Publication number
JP2019527228A5
JP2019527228A5 JP2019503748A JP2019503748A JP2019527228A5 JP 2019527228 A5 JP2019527228 A5 JP 2019527228A5 JP 2019503748 A JP2019503748 A JP 2019503748A JP 2019503748 A JP2019503748 A JP 2019503748A JP 2019527228 A5 JP2019527228 A5 JP 2019527228A5
Authority
JP
Japan
Prior art keywords
formula
compound
hydrogen
alkyl group
base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019503748A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019527228A (ja
JP6985367B2 (ja
Filing date
Publication date
Priority claimed from GBGB1613054.4A external-priority patent/GB201613054D0/en
Application filed filed Critical
Publication of JP2019527228A publication Critical patent/JP2019527228A/ja
Publication of JP2019527228A5 publication Critical patent/JP2019527228A5/ja
Application granted granted Critical
Publication of JP6985367B2 publication Critical patent/JP6985367B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019503748A 2016-07-28 2017-07-27 新規化合物および方法 Active JP6985367B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1613054.4A GB201613054D0 (en) 2016-07-28 2016-07-28 New compound and process
GB1613054.4 2016-07-28
PCT/GB2017/052190 WO2018020249A1 (en) 2016-07-28 2017-07-27 New compound and process

Publications (3)

Publication Number Publication Date
JP2019527228A JP2019527228A (ja) 2019-09-26
JP2019527228A5 true JP2019527228A5 (enExample) 2021-06-17
JP6985367B2 JP6985367B2 (ja) 2021-12-22

Family

ID=56936838

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019503748A Active JP6985367B2 (ja) 2016-07-28 2017-07-27 新規化合物および方法

Country Status (19)

Country Link
US (1) US10710998B2 (enExample)
EP (1) EP3490988B1 (enExample)
JP (1) JP6985367B2 (enExample)
KR (1) KR102396059B1 (enExample)
CN (1) CN109641891B (enExample)
CY (1) CY1122138T1 (enExample)
DK (1) DK3490988T3 (enExample)
ES (1) ES2751948T3 (enExample)
GB (1) GB201613054D0 (enExample)
HR (1) HRP20192109T1 (enExample)
HU (1) HUE046509T2 (enExample)
LT (1) LT3490988T (enExample)
PL (1) PL3490988T3 (enExample)
PT (1) PT3490988T (enExample)
RS (1) RS59566B1 (enExample)
SI (1) SI3490988T1 (enExample)
SM (1) SMT201900582T1 (enExample)
TW (1) TWI739871B (enExample)
WO (1) WO2018020249A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3142701T1 (en) 2014-05-12 2018-08-31 Verona Pharma Plc NEW TREATMENT
GB201502260D0 (en) 2015-02-11 2015-04-01 Verona Pharma Plc Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound
MX2022008805A (es) * 2020-01-17 2022-08-11 Lupin Ltd Metodos, procesos e intermedios para preparar compuestos cromanos.
KR20240004495A (ko) 2021-04-29 2024-01-11 쑤저우 선카디아 바이오파마수티컬즈 컴퍼니 리미티드 이소퀴놀론 화합물과 이의 용도
EP4450500A4 (en) * 2021-12-14 2025-10-15 Xizang Haisco Pharmaceutical Co Ltd TRICYCLIC FUSED HETEROCYCLIC PDE3/4 DUAL INHIBITOR AND ITS USE
GB202202297D0 (en) 2022-02-21 2022-04-06 Verona Pharma Plc Formulation production process
EP4378942A1 (en) 2022-12-02 2024-06-05 Sandoz AG Crystal form of a pde3/4 inhibitor
TW202506117A (zh) 2023-06-26 2025-02-16 英商維羅納製藥Plc公司 顆粒組成物
WO2025003643A1 (en) 2023-06-26 2025-01-02 Verona Pharma Plc Particulate composition comprising ensifetrine
WO2025052119A1 (en) 2023-09-06 2025-03-13 Verona Pharma Plc Ensifentrine for use in treating chronic obstructive pulmonary disease (copd)
US20250249008A1 (en) 2024-02-07 2025-08-07 Verona Pharma Plc Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease
WO2025168706A1 (en) 2024-02-07 2025-08-14 Verona Pharma Plc Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease
WO2025176871A1 (en) 2024-02-23 2025-08-28 Inke, S.A. Process for preparing pyrimido[6,1-a]isoquinoline-4-ones

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ185900A (en) 1976-12-10 1981-04-24 Hoechst Ag Pyrimido (6,1-a) isoquinolin-4-ones medicaments intermediate isoquinolines
FI64370C (fi) 1977-05-05 1983-11-10 Hoechst Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara pyimido-(6,1-a)isokinolin-2-imino-4-onderivat
DE2847693A1 (de) 1978-11-03 1980-05-22 Hoechst Ag Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen
DE3135831A1 (de) 1981-09-10 1983-04-28 Hoechst Ag, 6230 Frankfurt 9,10-substituierte 2-mesitylimino-3-alkyl-3,4,6,7-tetrahydro-2h-pyrimido(6,1-a)isochinolin-4-one, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CA1237429A (en) 1983-05-05 1988-05-31 Frank Kienzle Pyrimidone derivatives
CN100415743C (zh) * 1999-03-31 2008-09-03 韦尔纳利斯有限公司 嘧啶并[6,1-a] 异喹啉-4-酮衍生物
AR082601A1 (es) 2010-08-09 2012-12-19 Verona Pharma Plc Formas cristalinas de compuestos de pirimido[6,1-a]isoquinolin-4-ona
US9700558B2 (en) 2013-03-15 2017-07-11 Verona Pharma Plc Drug combination of PDE3/PDE4 inhibitor and muscarinic receptor antagonist
SI3142701T1 (en) 2014-05-12 2018-08-31 Verona Pharma Plc NEW TREATMENT
HUE055527T2 (hu) 2014-09-15 2021-12-28 Verona Pharma Plc RPL554-t tartalmazó folyékony inhalációs készítmény
GB201502260D0 (en) 2015-02-11 2015-04-01 Verona Pharma Plc Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound

Similar Documents

Publication Publication Date Title
JP2019527228A5 (enExample)
JP7440989B2 (ja) 2-[5-(3-クロロフェニル)-3-ヒドロキシピリジン-2-カルボニル]アミノ]酢酸を調製するための方法
JP6633539B2 (ja) 2−(2,4−ジフルオロフェニル)−1,1−ジフルオロ−1−(5−置換−ピリジン−2−イル)−3−(1h−テトラゾール−1−イル)プロパン−2−オールおよびその調製工程
KR102586087B1 (ko) 다이아릴티오하이단토인 화합물의 제조 방법
JP2018522724A (ja) シュウ酸アミド系配位子および銅触媒によるハロゲン化アリールのカップリング反応におけるその使用
RU2014137470A (ru) Способы и соединения, которые можно использовать для синтеза антагонистов рецепторов орексина-2
HRP20192109T1 (hr) Novi spoj i proces
JP6954456B2 (ja) スルファミン酸リチウムの製造方法及び新規スルファミン酸リチウム
CA3070070A1 (en) Intermediates useful for the synthesis of a selective inhibitor against protein kinase and processes for preparing the same
JP2014511387A5 (enExample)
KR20230135109A (ko) 3-(2-클로로티아졸-5-일)-8-메틸-7-옥소-6-페닐-2,3-디히드로티아졸로[3,2-a]피리미딘-4-이움-5-올레이트의거울상이성질체 풍부 형태의 제조 방법
JP2021504505A5 (enExample)
JP2019521165A5 (enExample)
JP2013527149A5 (enExample)
JP2012509267A5 (ja) (R)−3−(2,3−ジヒドロキシプロピル)−6−フルオロ−5−(2−フルオロ−4−ヨードフェニルアミノ)−8−メチルピリド[2,3−d]ピリミジン−4,7(3H,8H)−ジオンを製造するためのプロセス及びその中間体
JP7349551B2 (ja) 含フッ素ピリミジン化合物およびその製造方法
JP2010024173A (ja) 9−アミノシンコナアルカロイドの製造法
US11434224B2 (en) Processes for preparing a diaminopyrimidine derivative or acid addition salt thereof
WO2021193685A1 (ja) 含フッ素ピリミジン化合物およびその製造方法
EP3562807B1 (en) Processes for the preparation of pesticidal compounds
TWI915494B (zh) 製備富含鏡像異構型態的3-(2-氯噻唑-5-基)-8-甲基-7-氧代-6-苯基-2,3-二氫噻唑并[3,2-a]嘧啶-4-鎓-5-醇鹽的方法
JP4066630B2 (ja) 2−置換チオピリミジン−4−カルボン酸エステルの製法
JP7097363B2 (ja) 殺有害生物化合物の調製方法
JP2019514931A (ja) 除草剤としてのピリジニルイミダゾロン化合物を調製するプロセス
CN110878030A (zh) 一种基于n,s-缩醛化合物合成高烯丙基胺类化合物的方法